<html><head><title>Last Compo EcoR1 Capital, LLC</title></head><link rel="stylesheet" type="text/css" href="alphaleague_style.css"/>
                  <body><h2>EcoR1 Capital, LLC<br>#assets : 50<br>AUMs(M$) : 1,403</h2><table border="1" class="dataframe mystyle">
  <thead>
    <tr style="text-align: center;">
      <th></th>
      <th>name</th>
      <th>rpt_dt</th>
      <th>w</th>
      <th>name_prev</th>
      <th>rpt_dt_prev</th>
      <th>w_prev</th>
      <th>dw</th>
    </tr>
  </thead>
  <tbody>
    <tr>
      <th>98401F105</th>
      <td>XENCOR INC</td>
      <td>30September20</td>
      <td>12.5</td>
      <td>XENCOR INC</td>
      <td>30June20</td>
      <td>10.8</td>
      <td>1.7</td>
    </tr>
    <tr>
      <th>50127T109</th>
      <td>KURA ONCOLOGY INC</td>
      <td>30September20</td>
      <td><div p style="color:black;background:#dbfad2;">10.0</div></td>
      <td>KURA ONCOLOGY INC</td>
      <td>30June20</td>
      <td>5.5</td>
      <td><div p style="color:black;background:#dbfad2;">4.5</div></td>
    </tr>
    <tr>
      <th>75943R102</th>
      <td>RELAY THERAPEUTICS INC</td>
      <td>30September20</td>
      <td><div p style="color:black;background:#dbfad2;">9.7</div></td>
      <td>-</td>
      <td>-</td>
      <td>-</td>
      <td><div p style="color:black;background:#dbfad2;">9.7</div></td>
    </tr>
    <tr>
      <th>G72800108</th>
      <td>PROTHENA CORP PLC</td>
      <td>30September20</td>
      <td>6.7</td>
      <td>PROTHENA CORP PLC</td>
      <td>30June20</td>
      <td>7.2</td>
      <td>-0.5</td>
    </tr>
    <tr>
      <th>61775R105</th>
      <td>MORPHIC HLDG INC</td>
      <td>30September20</td>
      <td>5.5</td>
      <td>MORPHIC HLDG INC</td>
      <td>30June20</td>
      <td>5.6</td>
      <td>-0.1</td>
    </tr>
    <tr>
      <th>60468T105</th>
      <td>MIRATI THERAPEUTICS INC</td>
      <td>30September20</td>
      <td><div p style="color:black;background:#dbfad2;">5.4</div></td>
      <td>MIRATI THERAPEUTICS INC</td>
      <td>30June20</td>
      <td>3.0</td>
      <td><div p style="color:black;background:#dbfad2;">2.4</div></td>
    </tr>
    <tr>
      <th>68622P109</th>
      <td>ORIC PHARMACEUTICALS INC</td>
      <td>30September20</td>
      <td>4.7</td>
      <td>ORIC PHARMACEUTICALS INC</td>
      <td>30June20</td>
      <td>6.5</td>
      <td>-1.8</td>
    </tr>
    <tr>
      <th>05370A108</th>
      <td>AVIDITY BIOSCIENCES INC</td>
      <td>30September20</td>
      <td>4.2</td>
      <td>AVIDITY BIOSCIENCES INC</td>
      <td>30June20</td>
      <td>4.3</td>
      <td>-0.1</td>
    </tr>
    <tr>
      <th>64049K104</th>
      <td>NEOLEUKIN THERAPEUTICS INC</td>
      <td>30September20</td>
      <td>3.3</td>
      <td>NEOLEUKIN THERAPEUTICS INC</td>
      <td>30June20</td>
      <td>4.3</td>
      <td>-1.0</td>
    </tr>
    <tr>
      <th>032724106</th>
      <td>ANAPTYSBIO INC</td>
      <td>30September20</td>
      <td>3.3</td>
      <td>ANAPTYSBIO INC</td>
      <td>30June20</td>
      <td>5.0</td>
      <td>-1.7</td>
    </tr>
    <tr>
      <th>00973J101</th>
      <td>AKOUOS INC</td>
      <td>30September20</td>
      <td>3.2</td>
      <td>AKOUOS INC</td>
      <td>30June20</td>
      <td>3.2</td>
      <td>0.0</td>
    </tr>
    <tr>
      <th>045396108</th>
      <td>ASSEMBLY BIOSCIENCES INC</td>
      <td>30September20</td>
      <td><div p style="color:black;background:#f5d2ce;">2.9</div></td>
      <td>ASSEMBLY BIOSCIENCES INC</td>
      <td>30June20</td>
      <td>5.4</td>
      <td><div p style="color:black;background:#f5d2ce;">-2.5</div></td>
    </tr>
    <tr>
      <th>67080M103</th>
      <td>NURIX THERAPEUTICS INC</td>
      <td>30September20</td>
      <td><div p style="color:black;background:#dbfad2;">2.9</div></td>
      <td>-</td>
      <td>-</td>
      <td>-</td>
      <td><div p style="color:black;background:#dbfad2;">2.9</div></td>
    </tr>
    <tr>
      <th>03824M109</th>
      <td>APPLIED MOLECULAR TRANS INC</td>
      <td>30September20</td>
      <td>2.6</td>
      <td>APPLIED MOLECULAR TRANS INC</td>
      <td>30June20</td>
      <td>2.1</td>
      <td>0.5</td>
    </tr>
    <tr>
      <th>04965G109</th>
      <td>ATRECA INC</td>
      <td>30September20</td>
      <td>2.4</td>
      <td>ATRECA INC</td>
      <td>30June20</td>
      <td>2.3</td>
      <td>0.1</td>
    </tr>
    <tr>
      <th>374163103</th>
      <td>GERON CORP</td>
      <td>30September20</td>
      <td>2.3</td>
      <td>GERON CORP</td>
      <td>30June20</td>
      <td>3.0</td>
      <td>-0.7</td>
    </tr>
    <tr>
      <th>03969F109</th>
      <td>ARCUS BIOSCIENCES INC</td>
      <td>30September20</td>
      <td>2.2</td>
      <td>ARCUS BIOSCIENCES INC</td>
      <td>30June20</td>
      <td>3.3</td>
      <td>-1.1</td>
    </tr>
    <tr>
      <th>38341PAA0</th>
      <td>GOSSAMER BIO INC</td>
      <td>30September20</td>
      <td><div p style="color:black;background:#dbfad2;">2.2</div></td>
      <td>-</td>
      <td>-</td>
      <td>-</td>
      <td><div p style="color:black;background:#dbfad2;">2.2</div></td>
    </tr>
    <tr>
      <th>869367102</th>
      <td>SUTRO BIOPHARMA INC</td>
      <td>30September20</td>
      <td>2.2</td>
      <td>SUTRO BIOPHARMA INC</td>
      <td>30June20</td>
      <td>1.0</td>
      <td>1.2</td>
    </tr>
    <tr>
      <th>86877M209</th>
      <td>SURFACE ONCOLOGY INC</td>
      <td>30September20</td>
      <td>1.6</td>
      <td>SURFACE ONCOLOGY INC</td>
      <td>30June20</td>
      <td>2.4</td>
      <td>-0.8</td>
    </tr>
    <tr>
      <th>23255M105</th>
      <td>CYCLERION THERAPEUTICS INC</td>
      <td>30September20</td>
      <td>1.1</td>
      <td>CYCLERION THERAPEUTICS INC</td>
      <td>30June20</td>
      <td>1.1</td>
      <td>0.0</td>
    </tr>
    <tr>
      <th>38000Q102</th>
      <td>GLYCOMIMETICS INC</td>
      <td>30September20</td>
      <td>0.9</td>
      <td>GLYCOMIMETICS INC</td>
      <td>30June20</td>
      <td>0.5</td>
      <td>0.4</td>
    </tr>
    <tr>
      <th>019818103</th>
      <td>ALLOVIR INC</td>
      <td>30September20</td>
      <td>0.8</td>
      <td>-</td>
      <td>-</td>
      <td>-</td>
      <td>0.8</td>
    </tr>
    <tr>
      <th>53228P109</th>
      <td>LIFESCI ACQUISITION CORP</td>
      <td>30September20</td>
      <td>0.5</td>
      <td>-</td>
      <td>-</td>
      <td>-</td>
      <td>0.5</td>
    </tr>
    <tr>
      <th>05492W103</th>
      <td>BCTG ACQUISITION CORP</td>
      <td>30September20</td>
      <td>0.5</td>
      <td>-</td>
      <td>-</td>
      <td>-</td>
      <td>0.5</td>
    </tr>
    <tr>
      <th>210373106</th>
      <td>CONSTELLATION PHARMCETICLS I</td>
      <td>30September20</td>
      <td><div p style="color:black;background:#f5d2ce;">0.5</div></td>
      <td>CONSTELLATION PHARMCETICLS I</td>
      <td>30June20</td>
      <td>2.6</td>
      <td><div p style="color:black;background:#f5d2ce;">-2.1</div></td>
    </tr>
    <tr>
      <th>46565G104</th>
      <td>ITEOS THERAPEUTICS INC</td>
      <td>30September20</td>
      <td>0.4</td>
      <td>-</td>
      <td>-</td>
      <td>-</td>
      <td>0.4</td>
    </tr>
    <tr>
      <th>02083G100</th>
      <td>ALPINE IMMUNE SCIENCES INC</td>
      <td>30September20</td>
      <td>0.4</td>
      <td>-</td>
      <td>-</td>
      <td>-</td>
      <td>0.4</td>
    </tr>
    <tr>
      <th>46333X108</th>
      <td>IRONWOOD PHARMACEUTICALS INC</td>
      <td>30September20</td>
      <td>0.3</td>
      <td>IRONWOOD PHARMACEUTICALS INC</td>
      <td>30June20</td>
      <td>0.3</td>
      <td>0.0</td>
    </tr>
    <tr>
      <th>698102209</th>
      <td>PANACEA ACQUISITION CORP</td>
      <td>30September20</td>
      <td>0.3</td>
      <td>-</td>
      <td>-</td>
      <td>-</td>
      <td>0.3</td>
    </tr>
    <tr>
      <th>26818M108</th>
      <td>DYNE THERAPEUTICS INC</td>
      <td>30September20</td>
      <td>0.3</td>
      <td>-</td>
      <td>-</td>
      <td>-</td>
      <td>0.3</td>
    </tr>
    <tr>
      <th>244413209</th>
      <td>DEERFIELD HEALTHCARE TECH AC</td>
      <td>30September20</td>
      <td>0.3</td>
      <td>-</td>
      <td>-</td>
      <td>-</td>
      <td>0.3</td>
    </tr>
    <tr>
      <th>G4411D109</th>
      <td>HEALTH SCIENCES ACQ CORP 2</td>
      <td>30September20</td>
      <td>0.3</td>
      <td>-</td>
      <td>-</td>
      <td>-</td>
      <td>0.3</td>
    </tr>
    <tr>
      <th>00461U105</th>
      <td>ACLARIS THERAPEUTICS INC</td>
      <td>30September20</td>
      <td>0.2</td>
      <td>ACLARIS THERAPEUTICS INC</td>
      <td>30June20</td>
      <td>0.1</td>
      <td>0.1</td>
    </tr>
    <tr>
      <th>59101E103</th>
      <td>METACRINE INC</td>
      <td>30September20</td>
      <td>0.2</td>
      <td>-</td>
      <td>-</td>
      <td>-</td>
      <td>0.2</td>
    </tr>
    <tr>
      <th>501575104</th>
      <td>KYMERA THERAPEUTICS INC</td>
      <td>30September20</td>
      <td>0.2</td>
      <td>-</td>
      <td>-</td>
      <td>-</td>
      <td>0.2</td>
    </tr>
    <tr>
      <th>303020101</th>
      <td>FS DEV CORP</td>
      <td>30September20</td>
      <td>0.2</td>
      <td>-</td>
      <td>-</td>
      <td>-</td>
      <td>0.2</td>
    </tr>
    <tr>
      <th>69353Y103</th>
      <td>PMV PHARMACEUTICALS INC</td>
      <td>30September20</td>
      <td>0.1</td>
      <td>-</td>
      <td>-</td>
      <td>-</td>
      <td>0.1</td>
    </tr>
    <tr>
      <th>760273102</th>
      <td>REPARE THERAPEUTICS INC</td>
      <td>30September20</td>
      <td>0.1</td>
      <td>REPARE THERAPEUTICS INC</td>
      <td>30June20</td>
      <td>0.1</td>
      <td>0.0</td>
    </tr>
    <tr>
      <th>33830X104</th>
      <td>FIVE PRIME THERAPEUTICS INC</td>
      <td>30September20</td>
      <td>0.1</td>
      <td>FIVE PRIME THERAPEUTICS INC</td>
      <td>30June20</td>
      <td>0.1</td>
      <td>0.0</td>
    </tr>
    <tr>
      <th>30205M101</th>
      <td>EXICURE INC</td>
      <td>30September20</td>
      <td>0.1</td>
      <td>EXICURE INC</td>
      <td>30June20</td>
      <td>0.3</td>
      <td>-0.2</td>
    </tr>
    <tr>
      <th>G7709Q104</th>
      <td>ROYALTY PHARMA PLC</td>
      <td>30September20</td>
      <td>0.1</td>
      <td>ROYALTY PHARMA PLC</td>
      <td>30June20</td>
      <td>0.1</td>
      <td>0.0</td>
    </tr>
    <tr>
      <th>805111101</th>
      <td>SAVARA INC</td>
      <td>30September20</td>
      <td>0.0</td>
      <td>SAVARA INC</td>
      <td>30June20</td>
      <td>0.2</td>
      <td>-0.2</td>
    </tr>
    <tr>
      <th>45845P108</th>
      <td>INTERCEPT PHARMACEUTICALS IN</td>
      <td>30September20</td>
      <td>0.0</td>
      <td>INTERCEPT PHARMACEUTICALS IN</td>
      <td>30June20</td>
      <td>0.0</td>
      <td>0.0</td>
    </tr>
    <tr>
      <th>91381U101</th>
      <td>UNITY BIOTECHNOLOGY INC</td>
      <td>30September20</td>
      <td>0.0</td>
      <td>-</td>
      <td>-</td>
      <td>-</td>
      <td>0.0</td>
    </tr>
    <tr>
      <th>98419J206</th>
      <td>XOMA CORP DEL</td>
      <td>30September20</td>
      <td>0.0</td>
      <td>XOMA CORP DEL</td>
      <td>30June20</td>
      <td>0.0</td>
      <td>0.0</td>
    </tr>
    <tr>
      <th>G59665102</th>
      <td>MEIRAGTX HLDGS PLC</td>
      <td>30September20</td>
      <td>0.0</td>
      <td>MEIRAGTX HLDGS PLC</td>
      <td>30June20</td>
      <td>0.0</td>
      <td>0.0</td>
    </tr>
    <tr>
      <th>253031108</th>
      <td>-</td>
      <td>-</td>
      <td>-</td>
      <td>DICERNA PHARMACEUTICALS INC</td>
      <td>30June20</td>
      <td>5.1</td>
      <td><div p style="color:black;background:#f5d2ce;">-5.1</div></td>
    </tr>
    <tr>
      <th>90400D108</th>
      <td>-</td>
      <td>-</td>
      <td>-</td>
      <td>ULTRAGENYX PHARMACEUTICAL IN</td>
      <td>30June20</td>
      <td>2.9</td>
      <td><div p style="color:black;background:#f5d2ce;">-2.9</div></td>
    </tr>
    <tr>
      <th>31189P102</th>
      <td>-</td>
      <td>-</td>
      <td>-</td>
      <td>FATE THERAPEUTICS INC</td>
      <td>30June20</td>
      <td>1.5</td>
      <td>-1.5</td>
    </tr>
    <tr>
      <th>24823R105</th>
      <td>-</td>
      <td>-</td>
      <td>-</td>
      <td>DENALI THERAPEUTICS INC</td>
      <td>30June20</td>
      <td>1.3</td>
      <td>-1.3</td>
    </tr>
    <tr>
      <th>110122157</th>
      <td>-</td>
      <td>-</td>
      <td>-</td>
      <td>BRISTOL-MYERS SQUIBB CO</td>
      <td>30June20</td>
      <td>1.2</td>
      <td>-1.2</td>
    </tr>
    <tr>
      <th>359616109</th>
      <td>-</td>
      <td>-</td>
      <td>-</td>
      <td>FULCRUM THERAPEUTICS INC</td>
      <td>30June20</td>
      <td>1.1</td>
      <td>-1.1</td>
    </tr>
    <tr>
      <th>22663K107</th>
      <td>-</td>
      <td>-</td>
      <td>-</td>
      <td>CRINETICS PHARMACEUTICALS IN</td>
      <td>30June20</td>
      <td>1.1</td>
      <td>-1.1</td>
    </tr>
    <tr>
      <th>492327101</th>
      <td>-</td>
      <td>-</td>
      <td>-</td>
      <td>KEROS THERAPEUTICS INC</td>
      <td>30June20</td>
      <td>0.6</td>
      <td>-0.6</td>
    </tr>
    <tr>
      <th>75955J402</th>
      <td>-</td>
      <td>-</td>
      <td>-</td>
      <td>RELMADA THERAPEUTICS INC</td>
      <td>30June20</td>
      <td>0.6</td>
      <td>-0.6</td>
    </tr>
    <tr>
      <th>299734103</th>
      <td>-</td>
      <td>-</td>
      <td>-</td>
      <td>EVELO BIOSCIENCES INC</td>
      <td>30June20</td>
      <td>0.4</td>
      <td>-0.4</td>
    </tr>
    <tr>
      <th>74140Y101</th>
      <td>-</td>
      <td>-</td>
      <td>-</td>
      <td>PREVAIL THERAPEUTICS INC</td>
      <td>30June20</td>
      <td>0.4</td>
      <td>-0.4</td>
    </tr>
    <tr>
      <th>004225108</th>
      <td>-</td>
      <td>-</td>
      <td>-</td>
      <td>ACADIA PHARMACEUTICALS INC</td>
      <td>30June20</td>
      <td>0.4</td>
      <td>-0.4</td>
    </tr>
    <tr>
      <th>53228P208</th>
      <td>-</td>
      <td>-</td>
      <td>-</td>
      <td>LIFESCI ACQUISITION CORP</td>
      <td>30June20</td>
      <td>0.2</td>
      <td>-0.2</td>
    </tr>
    <tr>
      <th>55910K108</th>
      <td>-</td>
      <td>-</td>
      <td>-</td>
      <td>MAGENTA THERAPEUTICS INC</td>
      <td>30June20</td>
      <td>0.2</td>
      <td>-0.2</td>
    </tr>
    <tr>
      <th>221015100</th>
      <td>-</td>
      <td>-</td>
      <td>-</td>
      <td>CORVUS PHARMACEUTICALS INC</td>
      <td>30June20</td>
      <td>0.1</td>
      <td>-0.1</td>
    </tr>
    <tr>
      <th>729139105</th>
      <td>-</td>
      <td>-</td>
      <td>-</td>
      <td>PLIANT THERAPEUTICS INC</td>
      <td>30June20</td>
      <td>0.0</td>
      <td>0.0</td>
    </tr>
    <tr>
      <th>483347100</th>
      <td>-</td>
      <td>-</td>
      <td>-</td>
      <td>KALEIDO BIOSCIENCES INC</td>
      <td>30June20</td>
      <td>0.0</td>
      <td>0.0</td>
    </tr>
    <tr>
      <th>29446K106</th>
      <td>-</td>
      <td>-</td>
      <td>-</td>
      <td>EQUILLIUM INC</td>
      <td>30June20</td>
      <td>0.0</td>
      <td>0.0</td>
    </tr>
  </tbody>
</table></body></html>.